Valerie W Rusch Selected Research

Valerie W Rusch Research Topics

Disease

92	Neoplasms (Cancer) 05/2024 - 01/2002
37	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2002
32	Malignant Mesothelioma 12/2023 - 07/2003
29	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2002
20	Adenocarcinoma 11/2023 - 11/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2002
14	Adenocarcinoma of Lung 10/2022 - 04/2006
12	Mesothelioma 02/2024 - 05/2002
8	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 08/2003
5	Carcinoma (Carcinomatosis) 11/2011 - 07/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 05/2004
4	Atrial Fibrillation 01/2022 - 03/2007
4	Pain (Aches) 01/2021 - 05/2006
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2014 - 02/2011
3	Disease Progression 01/2023 - 10/2016
3	Residual Neoplasm 12/2017 - 11/2005
3	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 05/2004
3	Pathologic Complete Response 01/2016 - 02/2007
3	Hemorrhage 09/2011 - 09/2003
3	Thymoma (Thymic Carcinoma) 07/2009 - 12/2007
3	Infections 11/2006 - 01/2006
2	Leukemia 01/2023 - 02/2016
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Anastomotic Leak 04/2020 - 01/2019
2	Microsatellite Instability 12/2019 - 01/2018
2	Esophageal Squamous Cell Carcinoma 01/2019 - 03/2009
2	Lymphatic Metastasis 01/2017 - 11/2006
2	Wounds and Injuries (Trauma) 11/2014 - 07/2009
2	Malignant Pleural Effusion 04/2011 - 01/2011
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2008 - 11/2004
1	Frailty 01/2023
1	Neurofibromatoses (Neurofibromatosis) 01/2023
1	Vaccinia 01/2023
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2023
1	Fever (Fevers) 03/2022
1	Myocardial Infarction 01/2022
1	Pneumonia (Pneumonitis) 01/2022

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 10/2019 - 04/2006
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2011
7	MesothelinIBA 11/2023 - 03/2012
7	Tyrosine Kinase InhibitorsIBA 10/2022 - 02/2008
7	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 07/2003
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2007
5	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 05/2007
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 04/2006
5	Pemetrexed (MTA)FDA Link 02/2016 - 07/2003
4	Gefitinib (Iressa)FDA Link 05/2011 - 04/2006
3	atezolizumabIBA 10/2023 - 10/2022
3	PlatinumIBA 11/2022 - 07/2011
3	Circulating Tumor DNAIBA 11/2022 - 12/2017
3	Bevacizumab (Avastin)FDA Link 12/2016 - 02/2011
3	Colloids (Colloid)IBA 03/2013 - 02/2011
3	Tumor Biomarkers (Tumor Markers)IBA 07/2011 - 11/2004
2	Monoclonal AntibodiesIBA 01/2023 - 01/2019
2	B7-H1 AntigenIBA 01/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 12/2011
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 12/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 11/2012
2	AntigensIBA 09/2017 - 05/2012
2	AsbestosIBA 02/2016 - 01/2016
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2014 - 05/2002
2	MucinsIBA 08/2014 - 02/2011
2	Etoposide (VP 16)FDA LinkGeneric 08/2014 - 08/2009
2	enhanced green fluorescent proteinIBA 01/2011 - 08/2003
2	Phosphotransferases (Kinase)IBA 07/2008 - 05/2007
2	Therapeutic UsesIBA 01/2007 - 08/2005
2	Green Fluorescent ProteinsIBA 11/2006 - 05/2006
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2006 - 01/2002
1	Peptides (Polypeptides)IBA 11/2023
1	AntibodiesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	avelumabIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2022
1	Chimeric Antigen ReceptorsIBA 03/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022

Therapy/Procedure

66	Therapeutics 01/2023 - 01/2002
23	Radiotherapy 02/2024 - 07/2002
20	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
15	Esophagectomy 01/2023 - 02/2007
13	Neoadjuvant Therapy 12/2023 - 02/2007
13	Pneumonectomy (Lung Volume Reduction) 01/2022 - 08/2003
13	Thoracotomy 01/2019 - 07/2003
9	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 03/2006
9	Induction Chemotherapy 01/2023 - 05/2006
8	Immunotherapy 04/2024 - 12/2011
5	Adjuvant Chemotherapy 10/2019 - 10/2011
4	Segmental Mastectomy (Lumpectomy) 05/2024 - 10/2014
4	Chemoradiotherapy 08/2013 - 02/2007
3	Length of Stay 09/2012 - 03/2007
2	Precision Medicine 10/2022 - 12/2017
2	Aftercare (After-Treatment) 09/2017 - 09/2014
2	Investigational Therapies (Experimental Therapy) 01/2015 - 02/2008
2	Decompression 11/2014 - 01/2011
2	Drug Tapering 01/2007 - 08/2005
1	Electronic Nose 05/2024